Epilepsy is primarily treated symptomatically—that is, the majority of the available medications aim to suppress seizures ...

The discovery of CSMD1's role in epilepsy represents a crucial step forward in unravelling the genetic mysteries of epilepsy.

According to a recent study, in patients with frontotemporal dementia (FTD), epileptic seizures are significantly more common ...

A large study from Finland reveals epilepsy is more common in frontotemporal dementia (FTD) patients than previously ...

Lacosamide is a functionalized amino acid (with similarity to d-serine) that is approved by the US FDA and EMEA as an adjunctive therapy for partial-onset seizures. Lacosamide is believed to exert ...

Researchers at the University of São Paulo (USP) in Brazil have succeeded in showing, in an animal model, that the process of insulin resistance in the brain affects both Alzheimer's disease and ...

Seizures can provoke a wide variety of changes ... the body may shut down as a defense mechanism. In some people, this can present as PNES. PNES most often occur in people living with stress ...

Neurosteroids demonstrate significant therapeutic promise through the modulation of the GABA system and warrant further investigation.